Experience of the optic neuritis treatment trial.
James
J
Corbett
D000293:Adolescent; D000328:Adult; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000503:physiopathology; D009902:Optic Neuritis / Q000628:therapy*; D010919:Placebos; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D011379:Prognosis; D014792:Visual Acuity
D005938:Glucocorticoids; D010919:Placebos; D011241:Prednisone; D008775:Methylprednisolone